Business Insights - Contract Manufacturing Strategies
Business Insights - Contract Manufacturing Strategies
165 pages | Business Insight Press | Market Report | PDF | 1 MB
Several pharma companies, including Eli Lilly, BMS (Bristol-Myers Squibb), Merck KG, Novartis and Roche/Genentech are expanding their chemical and
biomanufacturing capacities. Others, such as Abbott, Bayer Healthcare, Boehringer- Ingelheim, Pfizer and Sanofi-Aventis have developed their own custom manufacturing business. The imminent profit squeeze might change the thinking of the pharma industry. Major companies, such as AstraZeneca, Roche, Pfizer and Schering have cost reduction programs underway. Pertinent manufacturing strategy reviews are part of the measures to restore profitability.
The file is attached to premium FileSonic account, please do not make any mirror for the file.
http://www.filesonic.com/file/...t_Manufacturing_Strategies.pdf